MK0724 IV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0724 IV, covering 2015-07-22 to 2015-07-22. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018) [Phase 2]